These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37505682)

  • 1. Regulation of Clostridial Toxin Gene Expression: A Pasteurian Tradition.
    Dupuy B
    Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Regulatory Networks That Control Clostridium difficile Toxin Synthesis.
    Martin-Verstraete I; Peltier J; Dupuy B
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27187475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Clostridial Toxins: Mechanisms and Roles in Disease.
    Orrell KE; Melnyk RA
    Microbiol Mol Biol Rev; 2021 Aug; 85(3):e0006421. PubMed ID: 34076506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxin B is essential for virulence of Clostridium difficile.
    Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
    Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of flagella in Clostridium difficile pathogenicity.
    Stevenson E; Minton NP; Kuehne SA
    Trends Microbiol; 2015 May; 23(5):275-82. PubMed ID: 25659185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human intestinal enteroids as a model of
    Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of Clostridioides difficile toxin production.
    Majumdar A; Govind R
    Curr Opin Microbiol; 2022 Feb; 65():95-100. PubMed ID: 34781095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers.
    Brouwer MS; Roberts AP; Hussain H; Williams RJ; Allan E; Mullany P
    Nat Commun; 2013; 4():2601. PubMed ID: 24131955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection.
    Smits WK; Lyras D; Lacy DB; Wilcox MH; Kuijper EJ
    Nat Rev Dis Primers; 2016 Apr; 2():16020. PubMed ID: 27158839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
    Doosti A; Mokhtari-Farsani A
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
    Lamont JT
    Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridial toxins: sensing a target in a hostile gut environment.
    Oezguen N; Power TD; Urvil P; Feng H; Pothoulakis C; Stamler JS; Braun W; Savidge TC
    Gut Microbes; 2012; 3(1):35-41. PubMed ID: 22356854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
    Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.
    Cowardin CA; Kuehne SA; Buonomo EL; Marie CS; Minton NP; Petri WA
    mBio; 2015 Jan; 6(1):. PubMed ID: 25626905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both, toxin A and toxin B, are important in Clostridium difficile infection.
    Kuehne SA; Cartman ST; Minton NP
    Gut Microbes; 2011; 2(4):252-5. PubMed ID: 21804353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence Plasmids of the Pathogenic Clostridia.
    Revitt-Mills SA; Vidor CJ; Watts TD; Lyras D; Rood JI; Adams V
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31111816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.